Elon Musk, the founder of Neuralink, has received authorization to initiate human trials involving a groundbreaking brain chip. This development holds the promise of potentially restoring full bodily mobility to individuals suffering from paralysis.
Elon Musk's company, Neuralink, is embarking on a remarkable journey with the launch of human trials.
Participants in the study will undergo brain surgery as part of the trial.
Elon Musk has been dedicated to the goal of connecting the human brain to computers using implants for the past five years.
Prior to this, Neuralink conducted experiments involving animals, although they encountered challenges, including the unfortunate death of a monkey during a video game experiment in 2022.
The trials involved macaque monkeys with implanted chips that communicated with computers via Bluetooth technology.
In April 2021, Neuralink showcased a monkey named Pager playing the computer game Pong solely through thought, without the use of a joystick.
This achievement was made possible by connecting the chip to the monkey's brain and utilizing a computer to anticipate the monkey's intentions.
Elon Musk initially expressed his interest in human testing as early as 2019, but formal requests to the FDA were only made in 2022.
Initially, the FDA expressed concerns about potential movement of implant components within the brain during removal, posing risks.
However, in May 2023, Neuralink received FDA approval to conduct their inaugural study involving human participants.
Looking ahead, Neuralink aims to significantly enhance human communication with AI and among humans, potentially mitigating the risks associated with artificial intelligence on a societal scale.
Also Read:Â Why is Elon Musk's company Neuralink facing federal investigation?